Thema: |
|
||
Autor: | Pezking | ||
Datum: | 14.05.21 16:59 | ||
Antwort auf: | Medikamente, Therapien, Impfstoffe, Krankenhäuser #3 von ChRoM | ||
"A study led by the University of Birmingham in collaboration with Public Health England found that antibodies against the virus were three-and-a-half times higher in those who had the second shot after 12 weeks compared with those who had it after a three-week interval. [https://www.theguardian.com/science/2021/may/14/delay-in-giving-second-jabs-of-pfizer-vaccine-improves-immunity] Wobei natürlich 200 SeniorInnen auch keine allzu große Testgruppe bilden. |
|||
< antworten > | |||